Journals - All Articles

Technical Review Article | Open Access | Published 2 July 2026 Sphingosomes: A Novel Vesicular Drug Delivery System Maimuna Fatima¹*, CV Sai Sravani¹, Dr. K. Latha*¹, M.Sujatha¹ | EJPPS | 312 (2026) https://doi.org/10.37521/ejpps31207 Back to Journals | Article |Summary | References | Author Abstract This novel drug delivery system strives to sustain drug effect at a pre-determined rate or keep up a relatively constant and effective drug amount within the body, along with c

Changing rooms act as critical control points within pharmaceutical manufacturing facilities, functioning as microbial airlocks that limit personnel‑borne contamination entering classified processing areas. This study presents a five‑year comparative analysis (2022–2025) of microorganisms recovered from changing rooms and adjacent corridors, spanning cleanroom Grades D, C, and B.

Technical Review Article | Open Access | Published 2 July 2026 Analytical Methodology for Pharmaceutical Extractables and Leachables: A Comprehensive Approach for Containers and Closures Sumeet Dwivedi¹*, Rajesh Kumar Chawla², Naresh Ambekar², Sweta S. Koka¹,Prerna Chaturvedi³ | EJPPS | 312 (2026) https://doi.org/10.37521/ejpps31208 Back to Journals | Article |Summary | References | Author Abstract The control of extractables and leachables (E&L) from pharmaceutical packa

Technical Review Article | Open Access | Published 2 July 2026 Mechanical Particle Size Reduction Strategies for BCS Class II Drugs: Beyond Nanocrystals and Nanosuspensions Dr. Adil Patel¹*, Rajesh Dodiya², Karishma Karia¹, Nirali Parmar¹ | EJPPS | 312 (2026) https://doi.org/10.37521/ejpps31210 Back to Journals | Article |Summary | References | Author Abstract Poor aqueous solubility of Biopharmaceutics Classification System (BCS) Class II drugs remains a major barrier to

Changing rooms act as critical control points within pharmaceutical manufacturing facilities, functioning as microbial airlocks that limit personnel‑borne contamination entering classified processing areas. This study presents a five‑year comparative analysis (2022–2025) of microorganisms recovered from changing rooms and adjacent corridors, spanning cleanroom Grades D, C, and B.

Technical Review Article | Open Access | Published 2 July 2026 Unique Device Identifier Deployment: Role and Challenges in Traceability and Expedited Device Approvals Across the European Union and United States Divyasree Baraneetharan, M Pharm¹*, Dr. Shivanand K Mutta, M Pharm, Ph D² | EJPPS | 312 (2026) https://doi.org/10.37521/ejpps31209 Back to Journals | Article |Summary | References | Author Abstract Unique Device Identifier (UDI) system has become an important regula

High-level bio-decontamination, which involves reducing microorganisms by 99.9999%, is essential in preventing Hospital Acquired Infections and controlling pandemics.

Technical Review Article | Open Access | Published 2 July 2026 Adapting a Monoclonal Antibody (mAb) Facility for Gene Therapy Production Alfred Penfold | EJPPS | 312 (2026) https://doi.org/10.37521/ejpps31206 Back to Journals | Article | Summary | References | Author Introduction Biopharmaceutical manufacturers are increasingly challenged to support a rapidly expanding therapeutic landscape where monoclonal antibodies (mAbs), viral vector gene therapies, and other advanced m